Ads
related to: acute leukemia in adults- Safety
Learn More About Well Characterized
Safety Profile.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Access & Resources
Support is Available for
You and Your Patients.
- Safety
Search results
Researchers discover that a type of childhood leukemia originates during fetal development
Medical Xpress· 6 days agoAcute myeloid leukemia is the second most common type of acute leukemia in childhood and can be...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 5 days agoAutolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company focused on T cell therapies for...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 5 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Autolus shares hold steady with Buy rating on Obe-cel market penetration By Investing.com
Investing.com· 6 days agoOn Thursday, Truist Securities maintained a Buy rating on shares of Autolus Therapeutics Plc...
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 5 days ago"The data presented at ASCO 2024 demonstrate efficient and specific modulation of the oncogenic transcription factor MYB, a target that historically has been difficult to drug, by RGT-61159 ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Eldridge family establishes hospital fund to help other families of children with cancer
Quad-City Times· 6 days agoHudson McKearney is a 7-year-old boy who loves superheroes. Just before his second birthday,...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 3 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 5 days agoWhat if there were tests that could tell you whether the following drugs were a good match for your...